SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Stifel Maintains Buy on IGM Biosciences, Raises Price Target to $67

Stifel maintains IGM Biosciences (NASDAQ:IGMS) with a Buy and raises the price target from $60 to $67.

Benzinga · 05/08/2020 17:32

Stifel maintains IGM Biosciences (NASDAQ:IGMS) with a Buy and raises the price target from $60 to $67.